This compound is a protected amino acid derivative featuring a spirocyclic framework. It is primarily used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the preparation of active pharmaceutical ingredients for antiviral therapies.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1129634-44-1
Guanidine
pharmaceutical intermediate
Ethyl 6,7-difluoro-1-methyl-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
pharmaceutical intermediate
2,6-dichloro-5-fluoronicotinamide
pharmaceutical intermediate
2-(5-Bromo-2-methylbenzoyl)-5-(4-fluorophenyl)thiophene
pharmaceutical intermediate
Potassium (S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylate
pharmaceutical intermediate
(S)-7-tert-Butoxycarbonylamino-5-azaspiro[2.4]heptane
research compound
(6S)-5-[(2-methylpropan-2-yl)oxycarbonyl]-5-azaspiro[2.4]heptane-6-carboxylic acid
VEIYKHIPSJIVRK-QMMMGPOBSA-N
CC(C)(C)OC(=O)N1CC2(CC2)C[C@H]1C(=O)O
—